During the past decade, Children's Specialty Center of Nevada II conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Specialty Center of Nevada II" #1 sponsor was "Children's Oncology Group" with 7 trials, followed by "Genzyme, a Sanofi Company" with 4 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "BioMarin Pharmaceutical" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Specialty Center of Nevada II" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator, "Dutch Childhood Oncology Group" with 1 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator and "EsPhALL" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Children's Specialty Center of Nevada II" are "Accelerated Phase Chronic Myelogenous Leukemia" (1 trials), "Acute Undifferentiated Leukemia" (1 trials), "Adult Kidney Wilms Tumor" (1 trials), "Adult Rhabdomyosarcoma" (1 trials) and "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative" (1 trials). Many other conditions were trialed in "Children's Specialty Center of Nevada II" in a lesser frequency.

Most popular intervention types in "Children's Specialty Center of Nevada II" are "Drug" (14 trials), "Other" (9 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Cytology Specimen Collection Procedure" (3 trials), "Doxorubicin Hydrochloride" (3 trials), "Cisplatin" (2 trials) and "Etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Children's Specialty Center of Nevada II" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Children's Specialty Center of Nevada II". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Children's Specialty Center of Nevada II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Children's Specialty Center of Nevada II, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".